Canada markets closed

Trevi Therapeutics, Inc. (TRVI)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.8300+0.0600 (+2.17%)
At close: 04:00PM EDT
2.8300 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-32,167
-29,065
-29,152
-33,940
-32,758
Depreciation & amortization
40
123
43
50
47
Stock based compensation
2,366
2,247
2,327
2,543
2,417
Change in working capital
1,286
-3,847
-1,231
1,509
1,058
Accounts Payable
88
-1,049
9
831
417
Other working capital
-28,116
-31,847
-28,334
-28,946
-29,032
Other non-cash items
576
557
520
974
227
Net cash provided by operating activites
-28,073
-31,710
-28,175
-28,946
-29,000
Cash flows from investing activities
Investments in property, plant and equipment
-
-137
-159
-
-32
Purchases of investments
-31,215
-9,932
-126,215
0
-
Sales/Maturities of investments
73,670
69,497
19,001
0
-
Net cash used for investing activites
-59,067
59,428
-107,373
0
-32
Cash flows from financing activities
Debt repayment
0
-9,504
-5,833
0
-
Common stock issued
116,688
1,710
105,410
21,183
3,135
Common stock repurchased
-1,213
-
-
-
-
Other financing activites
-178
-258
-247
-450
-461
Net cash used privided by (used for) financing activities
124,396
-7,910
111,307
20,775
16,720
Net change in cash
37,256
19,808
-24,241
-8,171
-12,312
Cash at beginning of period
29,318
12,589
36,830
45,001
57,313
Cash at end of period
66,574
32,397
12,589
36,830
45,001
Free Cash Flow
Operating Cash Flow
-28,073
-31,710
-28,175
-28,946
-29,000
Capital Expenditure
-
-137
-159
-
-32
Free Cash Flow
-28,116
-31,847
-28,334
-28,946
-29,032